DEF: Hims & Hers Schedules 2026 Annual Meeting

Hims & Hers Health, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually.

Summary

• Hims & Hers Health, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on Thursday, June 11, 2026, at 11:00 a.m. Pacific Time.
• Stockholders of record as of April 15, 2026, are entitled to vote.
• Key proposals include the election of nine director nominees, ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026, and an advisory vote on executive compensation.
• The company encourages stockholders to vote online, by telephone, or by mail prior to the meeting.
• Proxy materials are available online and were made available on or about April 28, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, primarily due to the company's strong reported financial performance in FY 2025 and its proactive approach to corporate governance and executive compensation alignment with stockholders. The virtual meeting format also suggests a focus on stockholder engagement and efficiency.

Positives

• The company is holding a virtual annual meeting, which is expected to increase accessibility and participation for stockholders.
• The Board of Directors unanimously recommends voting FOR all proposals, indicating strong internal alignment.
• The company highlights its 2025 business performance with significant revenue growth and net income.
• Executive compensation is designed to align with stockholder interests, with a significant portion at risk and subject to performance metrics.
• The company has adopted stock ownership guidelines for executives and directors to further align interests with stockholders.

Negatives

• Two current directors, Christiane Pendarvis and Patrick Carroll, M.D., are not being renominated, indicating a board transition.
• The company is a controlled company due to Mr. Dudum's voting power, which allows it to opt out of certain NYSE corporate governance rules, though it currently complies with most.
• Two Section 16 reports were inadvertently filed late in fiscal year 2025 for Ms. Boughton and Mr. Chi, indicating minor administrative lapses.
• Gross margin decreased to 74% in FY 2025 from 79% in FY 2024.

Risks

• The filing includes forward-looking statements that are subject to risks and uncertainties, and actual results may differ materially from expectations.
• The company is a controlled company, which could impact certain corporate governance standards.
• The company operates in a competitive talent market, particularly for AI expertise, which influences compensation strategies.
• The company's business is subject to various risks and uncertainties, as detailed in its most recently filed Annual Report on Form 10-K.

Future Outlook

The filing contains forward-looking statements regarding expected future financial and business performance, market opportunity, risk oversight, and compensation program design. However, it explicitly states there can be no assurance that actual results will not materially differ from expectations due to various risks and uncertainties.

Management Comments

• Andrew Dudum, Chief Executive Officer, Director and Chairman of the Board, expressed appreciation for continued support and interest in Hims & Hers.
• The Board of Directors unanimously recommends voting FOR all proposals presented at the Annual Meeting.

Industry Context

StockSavvy.ai notes that Hims & Hers is operating in the rapidly evolving digital health and wellness sector, facing competition for talent and navigating regulatory landscapes. The company's focus on a consumer-first platform and personalized care aligns with broader industry trends towards accessible and convenient healthcare solutions.

Management Changes

Corporate Governance

Related Party Transactions

• The spouse of former COO Melissa Baird was Chair and shareholder of Woolly Labs, Inc. (Vouched), a company that licensed identity verification software to Hims & Hers. Payments to Vouched totaled $2.7 million for the year ended December 31, 2025. This agreement is no longer considered a related party transaction as of July 1, 2025.

Stakeholder Impact

• Shareholders: The election of directors, ratification of auditors, and advisory vote on executive compensation directly impact shareholder governance. The company's financial performance and compensation practices are designed to align with shareholder interests.
• Employees: The company emphasizes employee well-being, growth mindset, and holistic benefits, including parental leave and equity awards for eligible employees.
• Management: Executive compensation is detailed, with a significant portion tied to performance and stock value, aiming to attract, retain, and motivate key talent.
• Directors: Compensation for directors includes cash retainers and equity awards, with a new option for directors to elect equity in lieu of cash retainers.

Next Steps

• Stockholders to vote on the election of directors, ratification of KPMG LLP, and advisory approval of executive compensation at the Annual Meeting.
• The Board of Directors will continue to review leadership structure and compensation programs.
• Stockholder proposals for the 2027 annual meeting must be received by December 29, 2026, for inclusion in the proxy statement.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new operational or financial performance data that would warrant a change in investment recommendation. While the company reported strong FY2025 results and has sound governance practices, the information presented is primarily procedural for the upcoming meeting.

Keywords

Hims & Hers, Proxy Statement, Annual Meeting, Stockholders, Director Election, Executive Compensation, KPMG LLP, Corporate Governance, Virtual Meeting